These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12072132)

  • 21. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of repeat offending among violent female offenders with psychotic and personality disorders.
    Putkonen H; Komulainen EJ; Virkkunen M; Eronen M; Lönnqvist J
    Am J Psychiatry; 2003 May; 160(5):947-51. PubMed ID: 12727700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
    Fyrö B; Petterson U; Sedvall G
    Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample.
    Faustman WO; Ringo DL; Faull KF
    Br J Psychiatry; 1993 Oct; 163():519-21. PubMed ID: 7504565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
    Westenberg HG; Verhoeven WM
    Acta Psychiatr Scand; 1988 Nov; 78(5):541-9. PubMed ID: 2466394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C; Eklundh T; Fernström V; Swedin A; Zachau AC
    J Psychiatr Res; 1995; 29(2):133-40. PubMed ID: 7545235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
    Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
    Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus.
    Gopal SC; Pandey A; Das I; Gangopadhyay AN; Upadhyaya VD; Chansuria JP; Singh TB
    Childs Nerv Syst; 2008 Jun; 24(6):713-6. PubMed ID: 18075745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.
    von Knorring L; Oreland L; Häggendal J; Magnusson T; Almay B; Johansson F
    J Neural Transm; 1986; 66(1):37-46. PubMed ID: 2426397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
    Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-use stability of monoamine metabolites in human cerebrospinal fluid.
    Strawn JR; Ekhator NN; Geracioti TD
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):301-6. PubMed ID: 11530989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S; Tsuchimine S; Kunugi H
    J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.